Godshall Douglas Evan's Form 4 filing
Shockwave Medical, Inc. (SWAV) · filed Aug 12, 2022
- Accession no.
- 0001209191-22-045715
- Filed
- Aug 12, 2022
- Trade date
- Aug 11, 2022
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 11 non-derivative transactions and 0 derivative transactions. Open-market sales total $8.42M. It was filed 1 day after the trade.
This filing was later replaced by the amendment 0001209191-22-059518 (Dec 2, 2022). Trade tables on this site use the amended version.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Godshall Douglas EvanCIK 0001404227 | Director, Officer (President & CEO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 11, 2022 | Common Stock | SSaleDisposed | −800 | $276.11 | −$220,888 | 142,126 | Direct | |
| Aug 11, 2022 | Common Stock | SSaleDisposed | −1,751 | $277.57 | −$486,025.07 | 140,375 | Direct | |
| Aug 11, 2022 | Common Stock | SSaleDisposed | −5,116 | $278.51 | −$1,424,857.16 | 135,259 | Direct | |
| Aug 11, 2022 | Common Stock | SSaleDisposed | −3,741 | $279.37 | −$1,045,123.17 | 131,518 | Direct | |
| Aug 11, 2022 | Common Stock | SSaleDisposed | −5,987 | $280.48 | −$1,679,233.76 | 125,531 | Direct | |
| Aug 11, 2022 | Common Stock | SSaleDisposed | −6,586 | $281.55 | −$1,854,288.3 | 118,945 | Direct | |
| Aug 11, 2022 | Common Stock | SSaleDisposed | −2,503 | $282.38 | −$706,797.14 | 116,442 | Direct | |
| Aug 11, 2022 | Common Stock | SSaleDisposed | −1,016 | $283.74 | −$288,279.84 | 115,426 | Direct | |
| Aug 11, 2022 | Common Stock | SSaleDisposed | −1,900 | $284.63 | −$540,797 | 113,526 | Direct | |
| Aug 11, 2022 | Common Stock | SSaleDisposed | −400 | $285.41 | −$114,164 | 113,126 | Direct | |
| Aug 11, 2022 | Common Stock | SSaleDisposed | −200 | $287.00 | −$57,400 | 112,926 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.